$PTLA Discloses agreed to terminate the Collaboration and License Agreement with Bristol-Myers Squibb Company and Pfizer, Inc. - filing (Portola Pharmaceuticals) $BMY $PFE
for the development and commercialization of andexanet alfa in Japan